NEWS

Press Releases

Clinical Trial for Patients with the KRAS-variant and Head and Neck Squamous Cell Carcinoma (HNSCC).

Here on MiraKind.org, we’ve already discussed how the KRAS-variant plays a role in breast cancer risk, ovarian cancer risk, effects of HRT in the KRAS-variant patients, and even autoimmunity! Now, we want…

Read More
background

Doing Our Part to Support COVID 19 Testing and Our Path Forward

In May, Dr. Joanne Weidhaas did a webinar and Q&A session with members of our MiraKind community to share how MiraKind was using its available resources to help increase testing availability for…

Read More
background

MiraKind.org announces $50,000 donation from George and Loretta Whitesides for COVID-19 Testing at Los Angeles-area Skilled Nursing and Senior Care Facilities

Program Expands Efforts by Los Angeles-based Molecular Genetics Company MiraDx to Provide COVID-19 Tests to Essential Workers via Philanthropic Donations to its Sister Non-Profit LOS ANGELES (April 13, 2020) — Mirakind.org, a…

Read More

MiraKind supports essential workforce organizations with free COVID-19 Testing

MiraKind is ready to distribute COVID-19 tests for free to essential workers, with funding from the generous philanthropic donations of our MiraKind community through our #330MillionTests.org site. We are currently prioritizing access…

Read More

MiraKind Responds to the COVID-19 Pandemic

At MiraKind, we believe knowledge is power. That belief has never held truer than today, as we face a global pandemic that can only be stamped out with knowledge–knowledge of who is…

Read More

Dr. Joanne Weidhaas to speak at TEDxCulverCity

Our founder, Dr. Joanne Weidhaas will be giving her first “TED talk” as an invited speaker at TEDxCulverCity on March 31, 2020! Joanne is a radiation oncologist and cancer researcher, and she…

Read More

Let’s learn more about Hormone Replacement Therapy – together!

We want to start with the basics about Hormone Replacement Therapy, so you can get up to speed on the importance of MiraKind’s new study. In this article, we’ll cover what Hormone…

Read More
businesswomen with tablet

New Partnership Alert: MiraKind & genneve

MiraKind is committed to providing our community with the best tools possible to tackle challenges in the arena of women’s health. This is why MiraKind is partnering with genneve, a first-of-its-kind telehealth…

Read More
Woman with arms crossed because HRT is safe for some women

More proof Hormone Replacement Therapy (HRT) is safe, effective, and beneficial for most women

When our team came across a recent Los Angeles Times Article entitled, “Once and for all: Hormone replacement is good for women” we were very intrigued. What we learned from this game-changing…

Read More
White blood cells of a human, photomicrograph panorama as seen under the microscope, 1000x zoom.

Important Findings From Our Recently Published KRAS-Variant Study

A new study by MiraKind’s Founder, Dr. Joanne Weidhaas, in collaboration with her team at the University of California, Los Angeles and City of Hope, has been published in the scientific journal…

Read More
Breast epithelial cells

New Research: “The KRAS-variant induces an epithelial-to-mesenchymal transition ‘EMT’ in normal breast epithelial cells”

As discussed in our previous Genetics series posts, the discovery of non-coding RNAs paved the way for changes in the Central Dogma and how we think about the flow of genetic information…

Read More
pipette

New Research: How Inherited DNA -Based Mutations Impact Immunotherapy

The partners on the UCLA research team have made new discoveries about how genetic mutations can help doctors predict patient responses to cancer-fighting immunotherapy drugs. In the past, we’ve spoken a lot…

Read More

DONATE

SUPPORT OUR RESEARCH

PARTICIPATE

HELP ADVANCE OUR RESEARCH